| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |